ProShare Advisors Portfolio holdings
AUM
$50.1B
1-Year Return
23.39%
This Quarter Return
-2.53%
1 Year Return
+23.39%
3 Year Return
+95.6%
5 Year Return
+167.57%
10 Year Return
+417.51%
AUM
$44.3B
AUM Growth
+$548M
(+1.3%)
Cap. Flow
+$2.39B
Cap. Flow
% of AUM
5.4%
Top 10 Holdings %
Top 10 Hldgs %
27.39%
Holding
2,291
New
20
Increased
497
Reduced
1,558
Closed
210
Top Buys
| 1 |
Apple
AAPL
|
$215M |
| 2 |
Eversource Energy
ES
|
$187M |
| 3 |
Microsoft
MSFT
|
$184M |
| 4 |
Erie Indemnity
ERIE
|
$182M |
| 5 |
Factset
FDS
|
$165M |
Top Sells
| 1 |
Cardinal Health
CAH
|
$48.8M |
| 2 |
Emerson Electric
EMR
|
$47.1M |
| 3 |
Walmart
WMT
|
$41.1M |
| 4 |
Williams-Sonoma
WSM
|
$36.2M |
| 5 |
IBM
IBM
|
$35.7M |
Sector Composition
| 1 | Technology | 30.94% |
| 2 | Consumer Staples | 10.31% |
| 3 | Consumer Discretionary | 10.1% |
| 4 | Financials | 9.92% |
| 5 | Industrials | 9.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
RGLS
2026
DELISTED
Regulus Therapeutics
RGLS
| $23.9K | ﹤0.01% |
13,671
-4,114
| -23% | -$7.2K |
|
2027
BRC Inc
BRCC
$179M
| $23.9K | ﹤0.01% |
11,442
-3,444
| -23% | -$7.2K |
|
2028
Nerdy
NRDY
$159M
| $23.9K | ﹤0.01% |
16,822
-4,528
| -21% | -$6.43K |
|
2029
NN Inc
NNBR
$125M
| $22.8K | ﹤0.01% |
10,072
-3,030
| -23% | -$6.85K |
|
2030
The Beauty Health Co
SKIN
$293M
| $21.6K | ﹤0.01% |
16,111
-4,848
| -23% | -$6.5K |
|
2031
Stereotaxis
STXS
$264M
| $21.5K | ﹤0.01% |
12,232
-3,681
| -23% | -$6.48K |
|
2032
Fate Therapeutics
FATE
$112M
| $21.2K | ﹤0.01% |
26,811
-6,834
| -20% | -$5.4K |
|
2033
ProKidney
PROK
$290M
| $21.1K | ﹤0.01% |
24,099
-6,780
| -22% | -$5.94K |
|
2034
WM Technology
MAPS
$134M
| $21.1K | ﹤0.01% |
18,656
-5,615
| -23% | -$6.35K |
|
2035
Tango Therapeutics
TNGX
$777M
| $20.8K | ﹤0.01% |
15,205
-3,319
| -18% | -$4.55K |
|
2036
MacroGenics
MGNX
$112M
| $20.5K | ﹤0.01% |
16,137
-4,147
| -20% | -$5.27K |
|
2037
Pliant Therapeutics
PLRX
$107M
| $20.4K | ﹤0.01% |
15,080
-3,851
| -20% | -$5.2K |
|
2038
Zentalis Pharmaceuticals
ZNTL
$121M
| $19.7K | ﹤0.01% |
12,370
-3,724
| -23% | -$5.92K |
|
2039
Coherus Oncology, Inc. Common Stock
CHRS
$158M
| $19.6K | ﹤0.01% |
24,331
-7,004
| -22% | -$5.65K |
|
2040
Wheels Up
UP
$1.6B
| $19.6K | ﹤0.01% |
19,417
-5,841
| -23% | -$5.9K |
|
2041
Blink Charging
BLNK
$120M
| $19.1K | ﹤0.01% |
20,827
-6,268
| -23% | -$5.75K |
|
2042
Lexicon Pharmaceuticals
LXRX
$389M
| $19K | ﹤0.01% |
41,162
-8,298
| -17% | -$3.82K |
|
|
NOVA
2043
DELISTED
Sunnova Energy
NOVA
| $18.7K | ﹤0.01% |
50,208
-12,426
| -20% | -$4.62K |
|
2044
Atossa Therapeutics
ATOS
$104M
| $18.4K | ﹤0.01% |
27,381
-8,241
| -23% | -$5.55K |
|
2045
Lineage Cell Therapeutics
LCTX
$281M
| $17.6K | ﹤0.01% |
38,865
-2,741
| -7% | -$1.24K |
|
2046
Caribou Biosciences
CRBU
$169M
| $16.3K | ﹤0.01% |
17,810
-5,360
| -23% | -$4.89K |
|
2047
Destination XL Group
DXLG
$66.3M
| $15.9K | ﹤0.01% |
10,863
-4,228
| -28% | -$6.17K |
|
2048
Ventyx Biosciences
VTYX
$171M
| $15.1K | ﹤0.01% |
13,156
-3,960
| -23% | -$4.55K |
|
2049
SES AI
SES
$421M
| $14.9K | ﹤0.01% |
28,697
-7,980
| -22% | -$4.16K |
|
2050
TScan Therapeutics
TCRX
$106M
| $14.7K | ﹤0.01% |
10,626
-2,514
| -19% | -$3.47K |
|